메뉴 건너뛰기




Volumn 82, Issue 12, 2015, Pages 835-842

Insulin pumps: Beyond basal-bolus

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

EID: 84983113065     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.82a.14127     Document Type: Article
Times cited : (7)

References (44)
  • 1
    • 0036518602 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes
    • Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25:593-598.
    • (2002) Diabetes Care , vol.25 , pp. 593-598
    • Pickup, J.1    Keen, H.2
  • 2
    • 84983114890 scopus 로고    scopus 로고
    • Accessed October 14
    • JDRF and BD collaborate to improve insulin pump delivery. www.bd.com/_Images/BD_JDRF_press_release_2010_tcm49-19552.pdf. Accessed October 14, 2015.
    • (2015)
  • 3
    • 84900459379 scopus 로고    scopus 로고
    • Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology insulin pump management task force
    • Grunberger G, Abelseth JM, Bailey TS, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology insulin pump management task force. Endocr Pract 2014; 20:463-489.
    • (2014) Endocr Pract , vol.20 , pp. 463-489
    • Grunberger, G.1    Abelseth, J.M.2    Bailey, T.S.3
  • 4
    • 0035488933 scopus 로고    scopus 로고
    • Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection
    • Tsui E, Barnie A, Ross S, Parkes R, Zinman B. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 2001; 24:1722-1727.
    • (2001) Diabetes Care , vol.24 , pp. 1722-1727
    • Tsui, E.1    Barnie, A.2    Ross, S.3    Parkes, R.4    Zinman, B.5
  • 5
    • 21544436847 scopus 로고    scopus 로고
    • A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes
    • Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28:1568-1573.
    • (2005) Diabetes Care , vol.28 , pp. 1568-1573
    • Herman, W.H.1    Ilag, L.L.2    Johnson, S.L.3
  • 6
    • 7444266730 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c
    • Retnakaran R, Hochman J, DeVries JH, et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 2004; 27:2590-2596.
    • (2004) Diabetes Care , vol.27 , pp. 2590-2596
    • Retnakaran, R.1    Hochman, J.2    DeVries, J.H.3
  • 7
    • 14644418463 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII
    • Hirsch IB, Bode BW, Garg S, et al; Insulin Aspart CSII/MDI Comparison Study Group. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005; 28:533-538.
    • (2005) Diabetes Care , vol.28 , pp. 533-538
    • Hirsch, I.B.1    Bode, B.W.2    Garg, S.3
  • 8
    • 84885200173 scopus 로고    scopus 로고
    • Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): a cross-sectional cohort study
    • Schreiver C, Jacoby U, Watzer B, Thomas A, Haffner D, Fischer DC. Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): a cross-sectional cohort study. Clin Endocrinol (Oxf) 2013; 79:641-647.
    • (2013) Clin Endocrinol (Oxf) , vol.79 , pp. 641-647
    • Schreiver, C.1    Jacoby, U.2    Watzer, B.3    Thomas, A.4    Haffner, D.5    Fischer, D.C.6
  • 9
    • 84881539226 scopus 로고    scopus 로고
    • Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections
    • Leinung MC, Thompson S, Luo M, Leykina L, Nardacci E. Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections. Endocr Pract 2013; 19:9-13.
    • (2013) Endocr Pract , vol.19 , pp. 9-13
    • Leinung, M.C.1    Thompson, S.2    Luo, M.3    Leykina, L.4    Nardacci, E.5
  • 11
    • 0028929207 scopus 로고
    • Implementation of treatment protocols in the Diabetes Control and Complications Trial
    • Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995; 18:361-376.
    • (1995) Diabetes Care , vol.18 , pp. 361-376
  • 12
    • 29144453326 scopus 로고    scopus 로고
    • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    • Nathan DM, Cleary PA, Backlund JY, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-2653.
    • (2005) N Engl J Med , vol.353 , pp. 2643-2653
    • Nathan, D.M.1    Cleary, P.A.2    Backlund, J.Y.3
  • 13
    • 0032511583 scopus 로고    scopus 로고
    • UK Prospective Diabetes Study (UKPDS) Group
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 16
    • 84983101325 scopus 로고    scopus 로고
    • Cost effectiveness of insulin pump therapy
    • Cohen N, Shaw J. Cost effectiveness of insulin pump therapy. Infusystems Asia 2007; 2:25-28.
    • (2007) Infusystems Asia , vol.2 , pp. 25-28
    • Cohen, N.1    Shaw, J.2
  • 17
    • 84983122857 scopus 로고    scopus 로고
    • Insulin pumps: closer to a pancreas
    • Accessed October 14, 2015
    • Tucker ME. Insulin pumps: closer to a pancreas. Diabetes Forecast. www.diabetesforecast.org/2015/mar-apr/insulin-pumps-closer-to-pancreas.html. Accessed October 14, 2015.
    • Diabetes Forecast
    • Tucker, M.E.1
  • 18
    • 0033857856 scopus 로고    scopus 로고
    • Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. Study Group for the Development of Pump Therapy in Diabetes
    • Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care 2000; 23:1232-1235.
    • (2000) Diabetes Care , vol.23 , pp. 1232-1235
    • Hanaire-Broutin, H.1    Melki, V.2    Bessières-Lacombe, S.3    Tauber, J.P.4
  • 19
    • 78049488149 scopus 로고    scopus 로고
    • Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3
    • Schmid V, Hohberg C, Borchert M, Forst T, Pfützner A. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3. J Diabetes Sci Technol 2010; 4:976-982.
    • (2010) J Diabetes Sci Technol , vol.4 , pp. 976-982
    • Schmid, V.1    Hohberg, C.2    Borchert, M.3    Forst, T.4    Pfützner, A.5
  • 20
    • 67649183171 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control
    • Moghissi ES, Korytkowski MT, DiNardo M, et al; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009; 15:353-369.
    • (2009) Endocr Pract , vol.15 , pp. 353-369
    • Moghissi, E.S.1    Korytkowski, M.T.2    DiNardo, M.3
  • 21
    • 63249128249 scopus 로고    scopus 로고
    • Intensive versus conventional glucose control in critically ill patients
    • NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297.
    • (2009) N Engl J Med , vol.360 , pp. 1283-1297
    • Finfer, S.1    Chittock, D.R.2    Su, S.Y.3
  • 22
    • 84875810987 scopus 로고    scopus 로고
    • Transitioning insulin pump therapy from the outpatient to the inpatient setting: a review of 6 years' experience with 253 cases
    • Cook CB, Beer KA, Seifert KM, Boyle ME, Mackey PA, Castro JC. Transitioning insulin pump therapy from the outpatient to the inpatient setting: a review of 6 years' experience with 253 cases. J Diabetes Sci Technol 2012; 6:995-1002.
    • (2012) J Diabetes Sci Technol , vol.6 , pp. 995-1002
    • Cook, C.B.1    Beer, K.A.2    Seifert, K.M.3    Boyle, M.E.4    Mackey, P.A.5    Castro, J.C.6
  • 23
    • 65549096016 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients
    • Bailon RM, Partlow BJ, Miller-Cage V, et al. Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. Endocr Pract 2009; 15:24-29.
    • (2009) Endocr Pract , vol.15 , pp. 24-29
    • Bailon, R.M.1    Partlow, B.J.2    Miller-Cage, V.3
  • 24
    • 77649085442 scopus 로고    scopus 로고
    • Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: a review of one institution's experience
    • Leonhardi BJ, Boyle ME, Beer KA, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: a review of one institution's experience. J Diabetes Sci Technol 2008; 2:948-962.
    • (2008) J Diabetes Sci Technol , vol.2 , pp. 948-962
    • Leonhardi, B.J.1    Boyle, M.E.2    Beer, K.A.3
  • 25
    • 84983189999 scopus 로고    scopus 로고
    • Accessed October 14, 2015
    • Department of Radiology, University of Wisconsin School of Medicine and Public Health. Precautions with implanted devices. www.radiology.wisc.edu/fileShelf/forReferring/PrecautionsWithImplantedDevices_CTandXRAY.php. Accessed October 14, 2015.
    • Precautions with implanted devices
  • 26
    • 84983171625 scopus 로고    scopus 로고
    • Medtronic MiniMed, Inc. Accessed October 14
    • Indications, contraindications, warnings and precautions. Medtronicdiabetes.com/important-safety-information. Medtronic MiniMed, Inc. Accessed October 14, 2015.
    • (2015) Medtronicdiabetes.com/important-safety-information
  • 27
    • 84983107105 scopus 로고    scopus 로고
    • Tandem Diabetes Care. Accessed October 14
    • T:slim user guide. www.tandemdiabetes.com/uploadedFiles/Content/_Configuration/Files/Manuals/tslim_User_Guide.pdf. Tandem Diabetes Care. Accessed October 14, 2015.
    • (2015)
  • 28
    • 84983192208 scopus 로고    scopus 로고
    • Insulet Corporation. Accessed October 14
    • OmniPod user guide. www.myomnipodtraining.com/pdf/OmniPod-User-Guide-UST400.pdf. Insulet Corporation. Accessed October 14, 2015.
    • (2015)
  • 29
    • 84983201200 scopus 로고    scopus 로고
    • Animas Corporation. Accessed October 14
    • Important safety information. Animas Vibe Insulin Pump and CGM System. www.animas.com/safety. Animas Corporation. Accessed October 14, 2015.
    • (2015)
  • 31
    • 84983128321 scopus 로고    scopus 로고
    • Disetronic Medical Systems, Inc, Accessed October 14, 2015
    • ACCU-CHEK Spirit insulin pump system. Pump user guide. www.accu-chekinsulinpumps.com/documents/PumpUserGuide.pdf. Disetronic Medical Systems, Inc. Accessed October 14, 2015.
    • Pump user guide
  • 32
    • 5344227613 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion during general anesthesia: a case report
    • White WA Jr, Montalvo H, Monday JM. Continuous subcutaneous insulin infusion during general anesthesia: a case report. AANA J 2004; 72:353-357.
    • (2004) AANA J , vol.72 , pp. 353-357
    • White, W.A.1    Montalvo, H.2    Monday, J.M.3
  • 33
    • 84875806109 scopus 로고    scopus 로고
    • Insulin pump therapy in the perioperative period: a review of care after implementation of institutional guidelines
    • Boyle ME, Seifert KM, Beer KA, et al. Insulin pump therapy in the perioperative period: a review of care after implementation of institutional guidelines. J Diabetes Sci Technol 2012; 6:1016-1021.
    • (2012) J Diabetes Sci Technol , vol.6 , pp. 1016-1021
    • Boyle, M.E.1    Seifert, K.M.2    Beer, K.A.3
  • 34
    • 84875807752 scopus 로고    scopus 로고
    • Comparison of insulin pump therapy (continuous subcutaneous insulin infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions
    • Corney SM, Dukatz T, Rosenblatt S, et al. Comparison of insulin pump therapy (continuous subcutaneous insulin infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions. J Diabetes Sci Technol 2012; 6:1003-1015.
    • (2012) J Diabetes Sci Technol , vol.6 , pp. 1003-1015
    • Corney, S.M.1    Dukatz, T.2    Rosenblatt, S.3
  • 35
    • 84873944879 scopus 로고    scopus 로고
    • Perioperative glycemic management in insulin pump patients undergoing noncardiac surgery
    • Abdelmalak B, Ibrahim M, Yared JP, Modic MB, Nasr C. Perioperative glycemic management in insulin pump patients undergoing noncardiac surgery. Curr Pharm Des 2012; 18:6204-6214.
    • (2012) Curr Pharm Des , vol.18 , pp. 6204-6214
    • Abdelmalak, B.1    Ibrahim, M.2    Yared, J.P.3    Modic, M.B.4    Nasr, C.5
  • 36
    • 65649109621 scopus 로고    scopus 로고
    • Transportation Security Administration, Accessed October 14, 2015
    • US Department of Homeland Security. Travelers with disabilities and medical conditions. www.tsa.gov/travel/special-procedures. Transportation Security Administration. Accessed October 14, 2015.
    • Travelers with disabilities and medical conditions
  • 37
    • 84983198967 scopus 로고    scopus 로고
    • Medtronic MiniMed, Inc. Accessed October 14
    • Medical emergency card/airport information. www.medtronicdiabetes.com/sites/default/files/library/support/Airport%20Information%20Card.pdf. Medtronic MiniMed, Inc. Accessed October 14, 2015.
    • (2015)
  • 38
    • 84983156091 scopus 로고    scopus 로고
    • Animas Corporation. Accessed October 14
    • Traveling with an insulin pump. www.animas.com/about-insulin-pump-therapy/traveling-with-diabetes. Animas Corporation. Accessed October 14, 2015.
    • (2015)
  • 39
    • 84983145538 scopus 로고    scopus 로고
    • Insulet Corporation. Accessed October 14
    • Tips for air travel with diabetes supplies. www.myomnipod.com/pdf/14986-AWAirTravelTipsFlyerR2-11-11.pdf. Insulet Corporation. Accessed October 14, 2015.
    • (2015)
  • 40
    • 80053409489 scopus 로고    scopus 로고
    • Changes in altitude cause unintended insulin delivery from insulin pumps: mechanisms and implications
    • King BR, Goss PW, Paterson MA, Crock PA, Anderson DG. Changes in altitude cause unintended insulin delivery from insulin pumps: mechanisms and implications. Diabetes Care 2011; 34:1932-1933.
    • (2011) Diabetes Care , vol.34 , pp. 1932-1933
    • King, B.R.1    Goss, P.W.2    Paterson, M.A.3    Crock, P.A.4    Anderson, D.G.5
  • 41
    • 77954830051 scopus 로고    scopus 로고
    • Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes
    • Bergenstal RM, Tamborlane WV, Ahmann A, et al; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010; 363:311-320.
    • (2010) N Engl J Med , vol.363 , pp. 311-320
    • Bergenstal, R.M.1    Tamborlane, W.V.2    Ahmann, A.3
  • 42
    • 84880274350 scopus 로고    scopus 로고
    • Threshold-based insulin-pump interruption for reduction of hypoglycemia
    • Bergenstal RM, KlonoffDC, Garg SK, et al; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013; 369:224-232.
    • (2013) N Engl J Med , vol.369 , pp. 224-232
    • Bergenstal, R.M.1    Klonoff, D.C.2    Garg, S.K.3
  • 43
    • 84983156103 scopus 로고    scopus 로고
    • Challenges and recent progress in the development of a closed-loop artificial pancreas
    • Bequette BW. Challenges and recent progress in the development of a closed-loop artificial pancreas. Annu Rev
    • Annu Rev
    • Bequette, B.W.1
  • 44
    • 84904574791 scopus 로고    scopus 로고
    • Outpatient glycemic control with a bionic pancreas in type 1 diabetes
    • Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014; 371:313-325.
    • (2014) N Engl J Med , vol.371 , pp. 313-325
    • Russell, S.J.1    El-Khatib, F.H.2    Sinha, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.